The abolition of succinate dehydrogenase (SDH) activity with dimethyl malonate limited succinate accumulation and prevented angiogenesis via blocking the HIF-1α/VEGF axis, revealing a new potential therapeutic strategy to attenuate neo-angiogenesis in arthritis (Li et al., 2018). The gene discussed is VEGFA; the disease is Arthritis.